Cite
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
MLA
Rosemary Rochford, et al. “A Long-Duration Dihydroorotate Dehydrogenase Inhibitor (DSM265) for Prevention and Treatment of Malaria.” Science Translational Medicine, vol. 7, July 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10fcc77c46ef071db2bb33bf845ab1ab&authtype=sso&custid=ns315887.
APA
Rosemary Rochford, Kristina S. Wickham, Xavier C. Ding, David A. Fidock, Margaret A. Phillips, Thomas Rueckle, Sandra March, Brice Campo, Anna Marie Zeeman, Andrea Ruecker, Iñigo Angulo-Barturen, Xiaoyi Deng, Sergio Wittlin, Michael J. Delves, Farah El Mazouni, Susan A. Charman, Diana R. Tomchick, Laura Maria Sanz Alonso, Jacqueline W. Njoroge, … Karen L. White. (2015). A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Science Translational Medicine, 7.
Chicago
Rosemary Rochford, Kristina S. Wickham, Xavier C. Ding, David A. Fidock, Margaret A. Phillips, Thomas Rueckle, Sandra March, et al. 2015. “A Long-Duration Dihydroorotate Dehydrogenase Inhibitor (DSM265) for Prevention and Treatment of Malaria.” Science Translational Medicine 7 (July). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10fcc77c46ef071db2bb33bf845ab1ab&authtype=sso&custid=ns315887.